Get the Stockscreener App
9.705
3.43%
-0.345
After Hours:
9.85
0.145
+1.49%
Cns Pharmaceuticals Inc stock is traded at $9.705, with a volume of 43,577.
It is down -3.43% in the last 24 hours and up +38.64% over the past month.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
See More
Previous Close:
$10.05
Open:
$9.865
24h Volume:
43,577
Relative Volume:
0.85
Market Cap:
$5.58M
Revenue:
-
Net Income/Loss:
$-17.06M
P/E Ratio:
-0.1372
EPS:
-70.7173
Net Cash Flow:
$-14.18M
1W Performance:
+8.38%
1M Performance:
+38.64%
6M Performance:
-31.46%
1Y Performance:
-86.22%
1-Day Range:
$9.2549
$10.27
1-Week Range:
$8.71
$10.59
52-Week Range:
$4.93
$221.94
Cns Pharmaceuticals Inc Stock (CNSP) Company Profile
Name
Cns Pharmaceuticals Inc
Sector
Industry
Phone
1-800-946-9185
Address
2100 WEST LOOP SOUTH, HOUSTON
Compare CNSP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNSP
Cns Pharmaceuticals Inc
|
9.705 | 5.77M | 0 | -17.06M | -14.18M | -70.72 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cns Pharmaceuticals Inc Stock (CNSP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-28-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Aug-24-20 | Initiated | Ladenburg Thalmann | Buy |
Cns Pharmaceuticals Inc Stock (CNSP) Latest News
Measuring CNS Pharmaceuticals Inc.’s beta against major indicesBond Market & Weekly Chart Analysis and Trade Guides - newser.com
What analyst consensus says on CNS Pharmaceuticals Inc. stockIndex Update & High Conviction Buy Zone Alerts - newser.com
What MACD and RSI say about CNS Pharmaceuticals Inc.Quarterly Risk Review & Real-Time Buy Zone Alerts - newser.com
What high frequency data says about CNS Pharmaceuticals Inc.Portfolio Return Report & Long-Term Growth Plans - newser.com
Will CNS Pharmaceuticals Inc. stock go up soonJuly 2025 Patterns & Daily Profit Maximizing Tips - newser.com
How CNS Pharmaceuticals Inc. stock benefits from global expansionJuly 2025 Sector Moves & Real-Time Market Sentiment Alerts - newser.com
Has CNS Pharmaceuticals Inc. found a price floor2025 Breakouts & Breakdowns & Technical Pattern Based Signals - newser.com
What technical models suggest about CNS Pharmaceuticals Inc.’s comeback - newser.com
Is CNS Pharmaceuticals Inc. forming a bottoming baseJuly 2025 Price Swings & Community Trade Idea Sharing Platform - newser.com
Using Bollinger Bands to evaluate CNS Pharmaceuticals Inc.2025 Technical Overview & Technical Pattern Alert System - newser.com
Published on: 2025-10-06 02:54:28 - newser.com
Published on: 2025-10-05 06:09:46 - newser.com
Will CNS Pharmaceuticals Inc. rebound enough to break evenInflation Watch & Expert Approved Trade Ideas - newser.com
Multi asset correlation models including CNS Pharmaceuticals Inc.Weekly Trend Recap & Long-Term Safe Investment Plans - newser.com
Custom strategy builders for tracking CNS Pharmaceuticals Inc.Weekly Market Summary & Expert Approved Momentum Ideas - newser.com
CNS Pharmaceuticals (NASDAQ:CNSP) Shares Down 3.3% – Time to Sell? - Defense World
Published on: 2025-10-01 05:57:30 - newser.com
What analysts say about CNS Pharmaceuticals Inc stockFederal Reserve Announcements & Explosive Capital Growth - earlytimes.in
Cns Pharmaceuticals Inc Stock (CNSP) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):